Skip to main content
SpringerLink
Log in

Volumenersatzlösungen

  • Chapter
  • First Online:
Die Anästhesiologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 1502 Accesses

Zusammenfassung

Volumenersatzlösungen werden seit vielen Jahrzehnten mit sehr guten Erfahrungen und Resultaten eingesetzt. Für eine möglichst zielgerichtete Therapie ist es wichtig, zwischen Flüssigkeitsverlusten ohne kolloidosmotisch wirksame Moleküle (wie Urin und Perspiratio) und Volumenverlusten, also Flüssigkeit mit onkotisch wirksamen Makromolekülen (Blutverluste oder Plasmaverluste aus dem Intravasalraum) zu unterscheiden. Diese unterschiedlichen Entitäten sollten durch einen entsprechend differenzierten Einsatz von Infusionslösungen – also Kristalloiden und Kolloiden – therapiert werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Pries AR, Secomb TW, Gaehtgens P (2000) The endothelial surface layer. Pflugers Arch 440:653–666

    Article  CAS  PubMed  Google Scholar 

  2. Pries AR, Kuebler WM (2006) Normal endothelium. Handb Exp Pharmacol 176(1):1–40

    Google Scholar 

  3. Jacob M, Chappell D, Rehm M (2007) Clinical update: perioperative fluid management. Lancet 369:1984–1986

    Article  PubMed  Google Scholar 

  4. Bruegger D, Jacob M, Rehm M, Loetsch M, Welsch U, Conzen P, Becker BF (2005) Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am J Physiol Heart Circ Physiol 289:H1993–H1999

    Article  CAS  PubMed  Google Scholar 

  5. Bruegger D, Schwartz L, Chappell D, Jacob M, Rehm M, Vogeser M, Christ F, Reichart B, Becker BF (2011) Release of atrial natriuretic peptide precedes shedding of the endothelial glycocalyx equally in patients undergoing on- and off-pump coronary artery bypass surgery. Basic Res Cardiol 106:1111. [Epub vor Druck]

    Article  CAS  PubMed  Google Scholar 

  6. Chappell D, Jacob M, Becker BF, Hofmann-Kiefer K, Conzen P, Rehm M (2008) Expedition glycocalyx. A newly discovered „Great Barrier Reef“. Anaesthesist 57:959–969

    Article  CAS  PubMed  Google Scholar 

  7. Rehm M, Zahler S, Lötsch M, Welsch U, Conzen P, Jacob M, Becker BF (2004) Endothelial glycocalyx as an additional barrier determining extravasation of 6 % hydroxyethyl starch or 5 % albumin solutions in the coronary vascular bed. Anesthesiology 100:1211–1223

    Article  CAS  PubMed  Google Scholar 

  8. Rehm M, Orth VH, Kreimeier U, Thiel M, Mayer S, Brechtelsbauer H, Finsterer U (2001) Changes in blood volume during acute normovolemic hemodilution with 5 % albumin or 6 % hydroxyethylstarch and intraoperative retransfusion. Anaesthesist 50:569–579

    Article  CAS  PubMed  Google Scholar 

  9. Rehm M, Orth V, Kreimeier U, Thiel M, Haller M, Brechtelsbauer H, Finsterer U (2000) Changes in intravascular volume during acute normovolemic hemodilution and intraoperative retransfusion in patients with radical hysterectomy. Anesthesiology 92:657–664

    Article  CAS  PubMed  Google Scholar 

  10. Rehm M, Haller M, Orth V, Kreimeier U, Jacob M, Dressel H, Mayer S, Brechtelsbauer H, Finsterer U (2001) Changes in blood volume and hematocrit during acute preoperative volume loading with 5 % albumin or 6 % hetastarch solutions in patients before radical hysterectomy. Anesthesiology 95:849–856

    Article  CAS  PubMed  Google Scholar 

  11. Jacob M, Rehm M, Orth V, Lötsch M, Brechtelsbauer H, Weninger E, Finsterer U (2003) Exact measurement of the volume effect of 6 % hydoxyethyl starch 130/0.4 (Voluven) during acute preoperative normovolemic hemodilution. Anaesthesist 52:896–904

    Article  CAS  PubMed  Google Scholar 

  12. Rehm M, Orth VH, Weninger E, Jacob M, Mayer S, Brechtelsbauer H, Finsterer U (2001) Acute „normovolemic“ hemodilution with 3,5 % polygel (Haemaccel) for patients in the Wertheim-Meigs-operation. Blood loss of 87 % blood volume without perioperative blood transfusion. Anaesthesist 50:580–584

    Article  CAS  PubMed  Google Scholar 

  13. Jacob M, Chappell D, Hofmann-Kiefer K, Helfen T, Schülke A, Jacob B, Conzen P, Rehm M (2010) Der intravasale Volumeneffekt von Ringer-Laktat ist kleiner als 20 %. DIVI Abstract P-01-12

    Google Scholar 

  14. Deetjen P, Lichtwarck-Aschoff M (2007) Interpreting acid-base balance using the Stewart approach. Anaesthesist 56:1185–1198

    Article  CAS  PubMed  Google Scholar 

  15. Funk GC (2007) Das Säure-Basen Modell nach Stewart. Wien Klin Wochenschr 119:390–403

    Article  CAS  PubMed  Google Scholar 

  16. Morgan TJ (2009) The Stewart approach – one clinician’s perspective. Clin Biochem Rev 30:41–54

    PubMed  PubMed Central  Google Scholar 

  17. Rehm M, Chappell D, Hofmann-Kiefer K (2007) Paradigm change due to the Stewart model of acid-base equilibrium? We must not re-learn but continue learning! Wien Klin Wochenschr 119:387–389

    Article  PubMed  Google Scholar 

  18. Rehm M, Conzen PF, Peter K, Finsterer U (2004) The Stewart model. „Modern“ approach to the interpretation of the acid-base metabolism. Anaesthesist 53:347–357

    Article  CAS  PubMed  Google Scholar 

  19. Rehm M, Orth V, Scheingraber S, Kreimeier U, Brechtelsbauer H, Finsterer U (2000) Acid-base changes caused by 5 % albumin versus 6 % hydroxyethyl starch solution in patients undergoing acute normovolemic hemodilution: a randomized prospective study. Anesthesiology 93:1174–1183

    Article  CAS  PubMed  Google Scholar 

  20. Scheingraber S, Heitmann L, Weber W, Finsterer U (2000) Are there acid base changes during transurethral resection of the prostate (TURP)? Anesth Analg 90:946–950

    Article  CAS  PubMed  Google Scholar 

  21. Scheingraber S, Rehm M, Sehmisch C, Finsterer U (1999) Anesthesiology 90:1265–1270

    Article  CAS  PubMed  Google Scholar 

  22. Morgan TJ, Venkatesh B, Hall J (2004) Crystalloid strong ion difference determines metabolic acid-base change during acute normovolaemic haemodilution. Intensive Care Med 30:1432–1437

    Article  PubMed  Google Scholar 

  23. Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG (2001) The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 93:811–816

    Article  CAS  PubMed  Google Scholar 

  24. O’Malley CM, Frumento RJ, Hardy MA, Benvenisty AI, Brentjens TE, Mercer JS, Bennett-Guerrero E (2005) A randomized, double-blind comparison of lactated Ringer’s solution and 0,9 % NaCl during renal transplantation. Anesth Analg 100:1518–1524

    Article  PubMed  CAS  Google Scholar 

  25. Levick JR (2004) Revision of the Starling principle: new views of tissue fluid balance. J Physiol 557:704

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Jacob M, Bruegger D, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF (2007) The endothelial glycocalyx affords compatibility of Starling’s principle and high cardiac interstitial albumin levels. Cardiovasc Res 73:575–586

    Article  CAS  PubMed  Google Scholar 

  27. Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF (2006) Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 104:1223–1231

    Article  CAS  PubMed  Google Scholar 

  28. Jacob M, Paul O, Mehringer L, Chappell D, Rehm M, Welsch U, Kaczmarek I, Conzen P, Becker BF (2009) Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation 87:956–965

    Article  PubMed  Google Scholar 

  29. Bennhold H, Peters H, Roth E (1954) Über einen Fall kompletter Analbuminämie ohne wesentliche Krankheitszeichen. Verh Dtsch Ges Inn Med 60:630–634

    Google Scholar 

  30. Chappell D, Jacob M, Rehm M (2007) Genetical analbuminemia is not an appropriate model for hypoalbuminemia in critically ill patients. Chest 132:1717–1718

    Article  PubMed  Google Scholar 

  31. Vincent JL (2009) Relevance of albumin in modern critical care medicine. Best Pract Res Clin Anaesthesiol 23:183–191

    Article  CAS  PubMed  Google Scholar 

  32. Youssef MA, Al-Inany HG, Evers JL, Aboulghar M (2011) Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev (2):CD001302

    Google Scholar 

  33. Laxenaire MC, Charpentier C, Feldman L (1994) Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French prospective multicentre enquiry. Ann Fr Anaesth Réanim 13:301–310

    Article  CAS  Google Scholar 

  34. Barron ME, Wilkes MM, Narvickis RJ (2004) A systematic review of the comparative safety of colloids. Arch Surg 193:552–563

    Article  Google Scholar 

  35. Alving BM, Hojima Y, Pisano JJ, Mason BL, Buckingham RE Jr, Mozen MM, Finlayson JS (1978) Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction. N Engl J Med 299:66–70

    Article  CAS  PubMed  Google Scholar 

  36. Victor R, Chan AK, Mattoon M (1988) Aluminum contamination in albumin solutions from glass storage. Transfusion 28:290–291

    Article  CAS  PubMed  Google Scholar 

  37. Erasmus RT, Kusnir J, Stevenson WC, Lobo P, Herman MM, Wills MR, Savory J (1995) Hyperaluminemia associated with liver transplantation and acute renal failure. Clin Transplant 9:307–311

    CAS  PubMed  Google Scholar 

  38. Greenough A, Cheeseman P, Kavvadia V, Dimitriou G, Morton M (2002) Colloid infusion in the perinatal period and abnormal neurodevelopmental outcome in very low birth weight infants. Eur J Pediatr 161:319–323

    Article  PubMed  Google Scholar 

  39. Bishop NJ, Morley R, Day JP, Lucas A (1997) Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med 336:1557–1561

    Article  CAS  PubMed  Google Scholar 

  40. European Pharmacopoeia 6.6 01/2010:0275 S 5264

    Google Scholar 

  41. Vincent JL, Wilkes MM, Navickis RJ (2003) Safety of human albumin – serious adverse events reported worldwide in 1998–2000. Br J Anaesth 91:625–630

    Article  CAS  PubMed  Google Scholar 

  42. Vincent JL, Dubois MC, Navickis RJ (2003) Hypoalbuminemia in acute illness: is there a rationale for Intervention? Ann Surg 237:319–334

    PubMed  PubMed Central  Google Scholar 

  43. Dubois MJ, Orella-Jimenez C, Melot C (2006) Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controled pilot study. Crit Care Med 34:2536–2540

    Article  CAS  PubMed  Google Scholar 

  44. Hayes GR, Navickis RJ, Wilkes MM (2003) Albumin administration – what is the evidence of clinical benefit? A systematic review of randomized controled trials. Eur J Anaesthesiol 20:771–793

    Article  Google Scholar 

  45. Martin GS, Moss M, Wheeler AP (2005) A randomized controled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 33:1681–1687

    Article  CAS  PubMed  Google Scholar 

  46. Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Br Med J 317:235–240

    Article  Google Scholar 

  47. Alderson P, Bunn F, Lefebvre C, Li WP, Li L, Roberts I, Schierhout G, Albumin Reviewers (2004) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev (4):CD001208

    Google Scholar 

  48. Finfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, Neal B, Norton R (2006) Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. Br Med J 333:1044

    Article  CAS  Google Scholar 

  49. SAFE Study Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service, George Institute for International Health, Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N, Kai Lo S, Vallance S (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357:874–884

    Article  Google Scholar 

  50. Vincent JL, Navickis RJ, Wilkes MM (2004) Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 32:2029–2038

    Article  CAS  PubMed  Google Scholar 

  51. SAFE Study Investigators, Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R (2011) Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 37:86–96

    Article  CAS  Google Scholar 

  52. Delaney AP, Dan A, McCaffrey J (2011) The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 39:386–391

    Article  CAS  PubMed  Google Scholar 

  53. Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, Nyeko R, Mtove G, Reyburn H, Lang T, Brent B, Evans JA, Tibenderana JK, Crawley J, Russell EC, Levin M, Babiker AG, Gibb DM, FEAST Trial Group (2011) Mortality after fluid bolus in African children with severe infection. N Engl J Med 364:2483–2495

    Article  CAS  PubMed  Google Scholar 

  54. Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, Ko TC, Paredes A (2011) Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 112:1289–1295

    Article  PubMed  PubMed Central  Google Scholar 

  55. Adams HA, Piepenbrock S, Hempelmann G (1998) Volumenersatzmittel – Pharmakologie und klinischer Einsatz. Anästhesiol Intensivmed Notfallmed Schmerzther 33:2–17

    Article  CAS  PubMed  Google Scholar 

  56. Auwerda JJ, Wilson JH, Sonneveld P (2002) Foamy macrophage syndrome due to hydroxyethyl starch replacement: a severe side effect in plasmapheresis. Ann Intern Med 137:1013–1014

    Article  PubMed  Google Scholar 

  57. Appelman MH, van Barneveld LJ, Romijn JW, Vonk AB, Boer C (2011) The impact of balanced hydroxylethyl starch cardiopulmonary bypass priming solution on the fibrin part of clot formation: ex vivo rotation thromboelastometry. Perfusion 26:175–180

    Article  PubMed  Google Scholar 

  58. Laubenthal H (1997) BSE und Heparin- bzw. Gelatinepräparate. Anaesthesist 46:253–254

    CAS  PubMed  Google Scholar 

  59. Druml W, Pölzleitner D, Laggner AN, Lenz K, Ulrich W (1988) Dextran-40, acute renal failure, and elevated plasma oncotic pressure [letter]. N Engl J Med 318:252–253

    Google Scholar 

  60. Ferraboli R, Malheiro PS, Abdulkader RC, Yu L, Sabbaga E, Burdmann EA (1997) Anuric acute renal failure caused by dextran 40 administration. Ren Fail 19:303–306

    Article  CAS  PubMed  Google Scholar 

  61. Tsang RK, Mok JS, Poon YS, van Hasselt A (2000) Acute renal failure in a healthy young adult after dextran 40 infusion for external-ear reattachment surgery. Br J Plast Surg 53:701–703

    Article  CAS  PubMed  Google Scholar 

  62. Berg EM, Fasting S, Sellevold OFM (1991) Serious complications with dextran-70 despite hapten prophylaxis. Anaesthesia 46:1033–1035

    Article  CAS  PubMed  Google Scholar 

  63. Laubenthal H, Messmer K (1992) Allergic reactions to dextrans. In: Baron J-F (Hrsg) Plasma volumen expansion, 1. Aufl. Arnette Blackwell, Paris, S 85–96

    Google Scholar 

  64. Laubenthal H, Messmer K (1992) Pharmacology of dextrans. In: Baron J-F (Hrsg) Plasma volume expansion, 1. Aufl. Arnette Blackwell, Paris, S 75–83

    Google Scholar 

  65. Laubenthal H, Sirtl C (1998) HES, Dextran und Gelatine – Indikationen und Verträglichkeit. Anasthesiol Intensivmed Notfallmed Schmerzther 33:251–255

    Article  CAS  PubMed  Google Scholar 

  66. Lutz H (1986) Plasmaersatzmittel, 4. Aufl. Thieme, Stuttgart/New York

    Google Scholar 

  67. Mardel SN, Saunders FM, Allen H, Menezes G, Edwards CM, Ollerenshaw L, Baddeley D, Kennedy A, Ibbotson RM (1998) Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 80:204–207

    Article  CAS  PubMed  Google Scholar 

  68. Mardel SN, Saunders FM, Ollerenshaw L, Edwards CM, Baddeley DT (1996) Reduced quality of in-vitro clot formation with gelatin-based plasma substitutes. Lancet 347:825

    Article  CAS  PubMed  Google Scholar 

  69. Tabuchi N, de Haan J, Gallandat Huet RC, Boonstra PW, van Oeveren W (1995) Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost 74:1447–1451

    Article  CAS  PubMed  Google Scholar 

  70. Griem W, Czok G, Lang K (1964) Histologische und physiologische Untersuchungen an Ratten nach Verabreichung des Plasmaexpanders Gelifundol. Anaesthesist 13:321–324

    CAS  PubMed  Google Scholar 

  71. Griem W, Czok G, Lang K (1964) Histologische und physiologische Untersuchungen an Ratten nach Haemaccel- und Rattenserum-Injektionen. Anaesthesist 13:324–330

    CAS  PubMed  Google Scholar 

  72. Griem W, Czok G, Lang K (1964) Histologische und physiologische Untersuchungen an Ratten nach Verabreichung des Plasmaexpanders Plasmagel. Anaesthesist 13:330–333

    CAS  PubMed  Google Scholar 

  73. Schabinski F, Oishi J, Tuche F, Luy A, Sakr Y, Bredle D, Hartog C, Reinhart K (2009) Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients. Intensive Care Med 35:1539–1547

    Article  CAS  PubMed  Google Scholar 

  74. Köhler M, Kaufmann I, Jacob M, Goeschl J, Rehm M (2011) Predictive value of endothelial glycocalyx shedding in septic shock. Infection 39:117–118

    Google Scholar 

  75. Dieterich HJ, Kraft D, Sirtl C, Laubenthal H, Schimetta W, Pölz W, Gerlach E, Peter K (1998) Hydroxyethyl starch antibodies in human – incidence and clinical relevance. Anesth Analg 86:1123–1126

    Article  CAS  PubMed  Google Scholar 

  76. Dieterich HJ (2003) Recent developments in European colloid solutions. J Trauma 54:S26–S30

    Article  CAS  PubMed  Google Scholar 

  77. Lenz K, Schimetta W, Pölz W, Kröll W, Gruy-Kapral C, Magometschnigg D (2000) Intestinal elimination of hydroxyethyl starch? Intensive Care Med 26(6):733–739

    Article  CAS  PubMed  Google Scholar 

  78. Asskali F, Förster H (1999) The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers. Anasthesiol Intensivmed Notfallmed Schmerzther 34:537–541

    Article  CAS  PubMed  Google Scholar 

  79. Christidis C, Mal F, Ramos J, Senejoux A, Callard P, Navarro R, Trinchet JC, Larrey D, Beaugrand M, Guettier C (2001) Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions. J Hepatol 35:726–732

    Article  CAS  PubMed  Google Scholar 

  80. Chappell D, Bruchelt W, Schenk W, Jacob M, Hofmann-Kiefer K, Conzen P, Kreimeier U, Rehm M (2008) Development of spontaneous subdural hematoma and bone marrow depression after hydroxyethyl starch administration. J Pediatr 153:579–581

    Article  CAS  PubMed  Google Scholar 

  81. Schmidt-Hieber M, Loddenkemper C, Schwartz S, Arntz G, Thiel E, Notter M (2006) Hydrops lysosomalis generalisatus – an underestimated side effect of hydroxyethyl starch therapy? Eur J Haematol 77:83–85

    Article  PubMed  Google Scholar 

  82. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620–1622

    Article  CAS  PubMed  Google Scholar 

  83. Dickenmann M, Oettl T, Mihatsch MJ (2008) Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 51:491–503

    Article  PubMed  Google Scholar 

  84. Lukasewitz P, Kroh U, Löwenstein O, Krämer M, Lennartz H (1998) Quantitative Untersuchungen zur Gewebespeicherung von mittelmolekularer Hydroxyethylstärke 200/0,5 bei Patienten mit Multiorganversagen. J Anästh Intensivbehandl 5:42–46

    Google Scholar 

  85. Sirtl C, Laubenthal H, Zumtobel V, Kraft D, Jurecka W (1999) Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. Br J Anaesth 82:510–515

    Article  CAS  PubMed  Google Scholar 

  86. Ständer S, Szépfalusi Z, Bohle B, Ständer H, Kraft D, Luger TA, Metze D (2001) Differential storage of hydroxyethyl starch (HES) in the skin: an immunoelectron-microscopical long-term study. Cell Tissue Res 304:261–269

    Article  PubMed  Google Scholar 

  87. Förster H (1992) Physical and chemical properties of hydroxyethyl starches. In: Baron J-F (Hrsg) Plasma volume expansion, 1. Aufl. Arnette Blackwell, Paris, S 105–120

    Google Scholar 

  88. Nitsch E (1998) Volumenersatz mit künstlichen Kolloiden. Anasthesiol Intensivmed Notfallmed Schmerzther 33:255–260

    Article  CAS  PubMed  Google Scholar 

  89. Waitzinger J, Bepperling F, Pabst G, Opitz J, Müller M, François BJ (1998) Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130/0.4)] after single-dose infusion of 6 % or 10 % solutions in healthy volunteers. Clin Drug Investig 16:151–160

    Article  CAS  PubMed  Google Scholar 

  90. Felfernig M, Franz A, Bräunlich P, Fohringer C, Kozek-Langenecker SA (2003) The effects of hydroxyethyl starch solutions on thromboelastography in preoperative male patients. Acta Anaesthesiol Scand 47:70–73

    Article  CAS  PubMed  Google Scholar 

  91. Innerhofer P, Fries D, Margreiter J, Klingler A, Kühbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W (2002) The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 95:858–865

    PubMed  Google Scholar 

  92. Haas T, Preinreich A, Oswald E, Pajk W, Berger J, Kuehbacher G, Innerhofer P (2007) Effects of albumin 5 % and artificial colloids on clot formation in small infants. Anaesthesia 62:1000–1007

    Article  CAS  PubMed  Google Scholar 

  93. Schramko A, Suojaranta-Ylinen R, Kuitunen A, Raivio P, Kukkonen S, Niemi T (2010) Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Br J Anaesth 104:691–697

    Article  CAS  PubMed  Google Scholar 

  94. Metze D, Reimann S, Szepfalusi Z, Bohle B, Kraft D, Luger TA (1997) Persistent pruritus after hydroxyethyl starch infusion therapy: a result of long-term storage in cutaneous nerves. Br J Dermatol 136:553–559

    Article  CAS  PubMed  Google Scholar 

  95. Bork K (2005) Pruritus precipitated by hydroxyethylstarch: a review. Br J Dermatol 152:3–12

    Article  CAS  PubMed  Google Scholar 

  96. Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF (2002) The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0,4 (6 %, 500 mL) in mild-to-severe renal impairment. Anesth Analg 95:544–551

    Article  CAS  PubMed  Google Scholar 

  97. Köhler H (1988) Der Einsatz von Volumenersatzmitteln bei Niereninsuffizienz und bei Dialysepatienten. Anaesthesiol Intensivmed 26:142–151

    Google Scholar 

  98. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139

    Article  CAS  PubMed  Google Scholar 

  99. Dart AB, Mutter TC, Ruth CA, Taback SP (2010) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev (1):CD007594

    Google Scholar 

  100. Wiedermann CJ (2008) Systematic review of randomized clinical trials on the use of hydroxyethyl starch for fluid management in sepsis. BMC Emerg Med 8:1

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  101. Zarychanski R, Turgeon AF, Fergusson DA, Cook DJ, Hébert P, Bagshaw SM, Monsour D, McIntyre L (2009) Renal outcomes and mortality following hydroxyethyl starch resuscitation of critically ill patients: systematic review and meta-analysis of randomized trials. Open Med 3:e196–e209. {Albumin, 2011 #94}

    PubMed  PubMed Central  Google Scholar 

  102. James MF, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS (2011) Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 107:693. [Epub ahead of print]

    Article  CAS  PubMed  Google Scholar 

  103. Treib J, Haass A, Pindur G, Wenzel E, Schimrigk K (1998) Blutungskomplikationen durch Hydroxyethylstärke sind vermeidbar – Komplikationen auch therapierbar. Dtsch Ärztebl 95:B-624–B-625

    Google Scholar 

  104. Mishler JM, Dürr H-K (1980) Macroamylasemia induced by hydroxyethyl starch – conformation by gel filtration analysis of serum and urine. Am J Clin Pathol 74:387–391

    Article  CAS  PubMed  Google Scholar 

  105. Kox WJ, Kox SN (1998) The influence of plasma substitutes on blood-typing and cross-matching. Baillière’s Clin Anaesthesiol 2:679–689

    Article  Google Scholar 

  106. Lagneau F, Beyne P, Letteron P, Laperche T, Marty J (1999) Fluid therapy directly interferes with immunoassay for cardiac troponin I. Intensive Care Med 25:625–627

    Article  CAS  PubMed  Google Scholar 

  107. Jacob M, Chappell D, Conzen P, Wilkes MM, Becker BF, Rehm M (2008) Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials. Crit Care 12:R34

    Article  PubMed  PubMed Central  Google Scholar 

  108. Schortgen F, Girou E, Deye N, Brochard L, CRYCO Study Group (2008) The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 34:2157–2168

    Article  PubMed  Google Scholar 

  109. Lescot T, Degos V, Zouaoui A, Preteux F, Coriat P, Puybasset L (2006) Opposed effects of hypertonic saline on contu-sions and noncontused brain tissue in patients with severe traumatic brain injury. Crit Care Med 34:3029–3033

    Article  CAS  PubMed  Google Scholar 

  110. Jousi M, Reitala J, Lund V, Katila A, Leppäniemi A (2010) The role of pre-hospital blood gas analysis in trauma resuscitation. World J Emerg Surg 5:10

    Article  PubMed  PubMed Central  Google Scholar 

  111. Bruegger D, Bauer A, Rehm M, Niklas M, Jacob M, Irlbeck M, Becker BF, Christ F (2005) Effect of hypertonic saline dextran on acid-base balance in patients undergoing surgery of abdominal aortic aneurysm. Crit Care Med 33:556–563

    Article  CAS  PubMed  Google Scholar 

  112. Cooper DJ (1999) Hypertonic saline resuscitation for head injured patients. Crit Care Resusc 1:161

    CAS  PubMed  Google Scholar 

  113. Helm M, Hauke J, Kohler J, Lampl L (2011) The concept of small volume resuscitation for preclinical trauma management. Experiences in the Air Rescue Service. Unfallchirurg 16:326. [Epub vor Druck]

    Google Scholar 

  114. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911–916

    Article  CAS  PubMed  Google Scholar 

  115. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256

    Article  CAS  PubMed  Google Scholar 

  116. Perel P, Roberts I (2011) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev (3):CD000567

    Google Scholar 

  117. Bunn F, Trivedi D, Ashraf S (2011) Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev (3):CD001319

    Google Scholar 

  118. Brandstrup B (2006) Fluid therapy for the surgical patient. Best Pract Res Clin Anaesthesiol 20:265–283

    Article  PubMed  Google Scholar 

  119. Rahbari NN, Zimmermann JB, Schmidt T, Koch M, Weigand MA, Weitz J (2009) Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg 96:331–341

    Article  CAS  PubMed  Google Scholar 

  120. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA (2011) Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39:259–265

    Article  PubMed  Google Scholar 

  121. Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR (2011) A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg 254:194–200

    Article  PubMed  Google Scholar 

  122. Nelson A, Berkestedt I, Schmidtchen A, Ljunggren L, Bodelsson M (2008) Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 30:623–627

    Article  CAS  PubMed  Google Scholar 

  123. Ogilvie MP, Pereira BM, McKenney MG, McMahon PJ, Manning RJ, Namias N, Livingstone AS, Schulman CI, Proctor KG (2010) First report on safety and efficacy of hetastarch solution for initial fluid resuscitation at a level 1 trauma center. J Am Coll Surg 210:870–880, 880–882

    Article  PubMed  Google Scholar 

  124. Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, Du B, McArthur C, Myburgh J, SAFE TRIPS Investigators (2010) Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 14:R185

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinikum der Universität München, Klinik für Anaesthesiologie, München, Deutschland

    Nikolai Hulde, Michaela Schwarz & Markus Rehm

Authors
  1. Nikolai Hulde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michaela Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Markus Rehm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nikolai Hulde .

Editor information

Editors and Affiliations

  1. Klinik für Anästhesiologie, Universitätsklinikum Aachen RWTH Aachen, Aachen, Germany

    Rolf Rossaint

  2. Klinik für Anästhesiologie, Universitätsklinikum Mainz, Mainz, Germany

    Christian Werner

  3. Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum München Klinikum Großhadern, München, Germany

    Bernhard Zwißler

Section Editor information

  1. Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Klinik für Anästhesiologie, Mainz, Deutschland

    Christian Werner

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hulde, N., Schwarz, M., Rehm, M. (2019). Volumenersatzlösungen. In: Rossaint, R., Werner, C., Zwißler, B. (eds) Die Anästhesiologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54507-2_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54507-2_26

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54505-8

  • Online ISBN: 978-3-662-54507-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation